Nutlin-3 is a small molecule inhibitor (targets p53-MDM2 interaction) [39] which has been shown to potentiate the p53 apoptosis pathway and sensitises the tumour cells to cisplatin cytotoxicity in metastatic and recurrent tumours [40, 41]. The gene discussed is TP53; the disease is neoplasm.